1. Home
  2. VERU vs WETO Comparison

VERU vs WETO Comparison

Compare VERU & WETO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERU
  • WETO
  • Stock Information
  • Founded
  • VERU 1971
  • WETO 2019
  • Country
  • VERU United States
  • WETO China
  • Employees
  • VERU N/A
  • WETO N/A
  • Industry
  • VERU Biotechnology: Pharmaceutical Preparations
  • WETO
  • Sector
  • VERU Health Care
  • WETO
  • Exchange
  • VERU Nasdaq
  • WETO NYSE
  • Market Cap
  • VERU 76.9M
  • WETO 81.4M
  • IPO Year
  • VERU 1990
  • WETO 2025
  • Fundamental
  • Price
  • VERU $0.54
  • WETO $4.20
  • Analyst Decision
  • VERU Strong Buy
  • WETO
  • Analyst Count
  • VERU 3
  • WETO 0
  • Target Price
  • VERU $4.33
  • WETO N/A
  • AVG Volume (30 Days)
  • VERU 2.0M
  • WETO 13.1K
  • Earning Date
  • VERU 05-07-2025
  • WETO 01-01-0001
  • Dividend Yield
  • VERU N/A
  • WETO N/A
  • EPS Growth
  • VERU N/A
  • WETO N/A
  • EPS
  • VERU N/A
  • WETO N/A
  • Revenue
  • VERU $16,886,419.00
  • WETO $6,326,827.00
  • Revenue This Year
  • VERU N/A
  • WETO N/A
  • Revenue Next Year
  • VERU N/A
  • WETO N/A
  • P/E Ratio
  • VERU N/A
  • WETO N/A
  • Revenue Growth
  • VERU 22.46
  • WETO N/A
  • 52 Week Low
  • VERU $0.45
  • WETO $3.10
  • 52 Week High
  • VERU $1.75
  • WETO $4.29
  • Technical
  • Relative Strength Index (RSI)
  • VERU 49.37
  • WETO N/A
  • Support Level
  • VERU $0.51
  • WETO N/A
  • Resistance Level
  • VERU $0.56
  • WETO N/A
  • Average True Range (ATR)
  • VERU 0.04
  • WETO 0.00
  • MACD
  • VERU 0.00
  • WETO 0.00
  • Stochastic Oscillator
  • VERU 38.00
  • WETO 0.00

About VERU Veru Inc.

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.

About WETO WEBUS INTERNATIONAL LIMITED

Webus International Ltd operates on a business model of Mobility-as-a-Service to identify and solve inefficiencies associated with inflexible or low-quality public transportation and provide cost-efficient and customized mass transportation services under different scenarios with comprehensive digital platforms. It offers commute shuttle service, customized chartered bus service, packaged tour service and other service to customers.

Share on Social Networks: